Darifenacin hydrobromide

Details

Files
Generic Name:
Darifenacin hydrobromide
Project Status:
Complete
Therapeutic Area:
Bladder, overactive
Manufacturer:
Novartis Pharmaceuticals Canada Inc.
Brand Name:
Enablex
Project Line:
Reimbursement Review
Project Number:
SR0061-000
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Bladder, overactive
Recommendation Type:
Do not list
Final Recommendation: